North America Drug Delivery Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Drug Delivery Market Analysis

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Frequently Asked Questions

The market is segmented based on , By Type (Conventional, Advanced), Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030. .
The North America Drug Delivery Market size was valued at USD 720.57 USD Billion in 2022.
The North America Drug Delivery Market is projected to grow at a CAGR of 6.9% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann-La Roche , Mylan N.V., Teva Pharmaceutical Industries , Sanofi, Pfizer , GSK plc, Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, Sun Pharmaceutical Industries , Merck & Co. , Lilly, 3M, Bayer AG, Astellas Pharma , AbbVie , Takeda Pharmaceutical Company Limited,.
The market report covers data from the U.S., Canada and Mexico in North America.